The Brain Health Study: A Pragmatic, Patient-Centered Trial

Study acronym: eRADAR
StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Results posted: Oct 6, 2026 Show 7 more changesShow less
    • Primary endpoint revised
    • Enrollment target: 1271 to 1261
    • Secondary endpoints: 14 to 12
    • Site details revised at 1 of 3 sites
    • Publications: details revised at 4 of 4 entries
    • Eligibility criteria expanded, about 3 words
    • Study description expanded, about 2 words
  2. Study completion date: Oct 6, 2025 to Jan 26, 2026v8
  3. Primary completion date: Apr 5, 2025 to Oct 6, 2025v7
  4. Trial status: Active, Not Recruiting to Completed
    • Enrollment target: estimated 1350 to confirmed 1271
    • Study completion date changed from estimate of Oct 5, 2025 to Oct 6, 2025
    v6
  5. Primary completion date changed from estimate of Mar 31, 2025 to Apr 5, 2025
    • Study completion date: Sep 30, 2025 to Oct 5, 2025
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Publications reorderedv4
  2. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 3 of 3 sites
    • Publications: 1 to 4
    v3
  3. Study description expanded, about 2 wordsv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The eRADAR Brain Health Study is an embedded, pragmatic clinical trial to determine whether targeted screening for dementia using the eRADAR algorithm increases dementia detection within primary care compared to usual care.
Trial Details
NCT Number NCT05905796
Lead Sponsor University of California, San Francisco
Collaborators: Kaiser Permanente, National Institute on Aging (NIA)
Conditions
(from sponsor)		 Dementia, Alzheimer Disease
Related terms Alzheimer Disease, Dementia
Enrollment 1,261 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov